| Particulars |
|
|
|
| Company Name
| Mankind Pharma Ltd
| Year End
| 202403
|
| Full Year |
| Equity (₹ Cr.) |
41.26 |
B.V. (₹) |
334.20 |
| Sales(₹ Cr.) |
9,264.81 |
NP (₹ Cr.) |
1,715.30 |
| NP Var% |
41.00 |
Div% |
0.00 |
| CPS(₹) |
49.30 |
EPS (₹) |
41.60 |
| Traded Value(₹ Lakhs) |
319.65 |
52 Week High |
3,050.00 |
| 52 Week Low |
1,910.00 |
Price BSE |
2,498.00 |
| Price NSE |
2,500.00 |
Market Capital (₹ Cr.) |
103,053.87 |
| P/C Ratio |
50.70 |
P/E Ratio |
60.10 |
| Price Vs.BV |
7.47 |
|
| Latest Quarter |
| Year End |
202412 |
Sales (₹ Cr.) |
2,396.57 |
| NP(₹ Cr.) |
416.38 |
NP Var % |
-10.00 |
| Trailing Twelve Months |
| Year End |
202412 |
Sales |
9,288.12 |
| OPM |
25.38 |
NP |
2,004.35 |
| NP Var% |
23.14 |
EPS |
46.87 |
| PE |
53.29 |
|
|